Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

S. Luminari, E. Viel, A.J.M. Ferreri, F. Zaja, E. Chimienti, G. Musuraca, A. Tucci, M. Balzarotti, M. Tani, F. Salvi, E.A. Pesce, A. Ferrari, A.M. Liberati, A. Spadea, D. Marino, M. Bruno-Ventre, S. Volpetti, C. Bottelli, E. Ravaioli, F. MerliM. Spina

Research output: Contribution to journalArticle

Original languageItalian
Pages (from-to)68-75
Number of pages8
JournalHematological Oncology
Volume36
Issue number1
DOIs
Publication statusPublished - 2018

Cite this

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi. / Luminari, S.; Viel, E.; Ferreri, A.J.M.; Zaja, F.; Chimienti, E.; Musuraca, G.; Tucci, A.; Balzarotti, M.; Tani, M.; Salvi, F.; Pesce, E.A.; Ferrari, A.; Liberati, A.M.; Spadea, A.; Marino, D.; Bruno-Ventre, M.; Volpetti, S.; Bottelli, C.; Ravaioli, E.; Merli, F.; Spina, M.

In: Hematological Oncology, Vol. 36, No. 1, 2018, p. 68-75.

Research output: Contribution to journalArticle

@article{c692325e3df2413cba1e9eaf9f44e389,
title = "Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi",
author = "S. Luminari and E. Viel and A.J.M. Ferreri and F. Zaja and E. Chimienti and G. Musuraca and A. Tucci and M. Balzarotti and M. Tani and F. Salvi and E.A. Pesce and A. Ferrari and A.M. Liberati and A. Spadea and D. Marino and M. Bruno-Ventre and S. Volpetti and C. Bottelli and E. Ravaioli and F. Merli and M. Spina",
note = "Cited By :3 Export Date: 31 January 2019",
year = "2018",
doi = "10.1002/hon.2425",
language = "Italian",
volume = "36",
pages = "68--75",
journal = "Hematological Oncology",
issn = "0278-0232",
publisher = "wiley",
number = "1",

}

TY - JOUR

T1 - Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi

AU - Luminari, S.

AU - Viel, E.

AU - Ferreri, A.J.M.

AU - Zaja, F.

AU - Chimienti, E.

AU - Musuraca, G.

AU - Tucci, A.

AU - Balzarotti, M.

AU - Tani, M.

AU - Salvi, F.

AU - Pesce, E.A.

AU - Ferrari, A.

AU - Liberati, A.M.

AU - Spadea, A.

AU - Marino, D.

AU - Bruno-Ventre, M.

AU - Volpetti, S.

AU - Bottelli, C.

AU - Ravaioli, E.

AU - Merli, F.

AU - Spina, M.

N1 - Cited By :3 Export Date: 31 January 2019

PY - 2018

Y1 - 2018

U2 - 10.1002/hon.2425

DO - 10.1002/hon.2425

M3 - Articolo

VL - 36

SP - 68

EP - 75

JO - Hematological Oncology

JF - Hematological Oncology

SN - 0278-0232

IS - 1

ER -